Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study

Ähnliche Einträge

• Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen risk and cardiovascular health study
  von: Meinitzer, Andreas, et al.
  Veröffentlicht: (2011)
• Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease
  von: Zewinger, Stephen, et al.
  Veröffentlicht: (2017)
• Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease
  Veröffentlicht: (2010)
• Increased plasma concentrations of soluble ST2 independently predict mortality but not cardiovascular events in stable coronary heart disease patients: 13-year follow-up of the KAROLA study
  von: Pfetsch, Vanessa, et al.
  Veröffentlicht: (2017)
• Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease
  von: Böger, Rainer H., et al.
  Veröffentlicht: (2011)